Scientists from University College London and Imperial College London have demonstrated how polymyxin antibiotics pierce the outer membrane of Escherichia coli bacteria [1, 2].
This discovery provides a visual map of how medications breach bacterial defenses. Understanding this process is critical for developing new treatments to combat the rise of drug-resistant infections [3, 4].
Using high-resolution microscopy in laboratory experiments, the team captured the precise moments the antibiotic armor is compromised [3]. The researchers tracked the process across specific time points, producing images at 15, 30, and 60 minutes after the bacteria were exposed to the drugs [5].
Polymyxins are described as life-saving antibiotics that act by puncturing the protective layer of harmful bacteria [6]. While some reports describe them as a last-resort option, their ability to dismantle the bacterial cell wall remains a primary mechanism for treating severe infections [3, 6].
The research comes amid growing concerns over multidrug-resistant bloodstream infections in Europe. According to data, only five capsule types are responsible for 70 percent of these resistant infections [7].
By visualizing the physical destruction of the E. coli membrane, the team has provided a blueprint for how other antibiotics might be engineered. The study focuses on the mechanical failure of the bacterial shell, an essential step in neutralizing the pathogen before it can spread through the bloodstream [3, 4].
“Polymyxins are life-saving antibiotics that pierce the armour of harmful bacteria.”
The ability to visualize the exact timing and method of membrane penetration allows scientists to move from theoretical models to observable evidence. This provides a tangible target for pharmaceutical development, potentially leading to the creation of synthetic antibiotics that can bypass the specific 'armor' configurations of the most common drug-resistant bacterial strains.
